Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Completed 48Terminated 8Recruiting 8Withdrawn 4Unknown 4Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Sarcoma 3Gynecologic 1Classical hematology 1

Conditions

Sarcoma 3Sarcoma, Ewing 1Rhabdomyosarcoma 1Ovarian Neoplasms 1Osteosarcoma 1Fanconi Anemia, Complementation Group D1 1Chondrosarcoma 1Bone Neoplasms 1

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Interventional × Trabectedin × Clear all
NCT03985722 2023-03-27

OLATRASTS

Grupo Espanol de Investigacion en Sarcomas

Phase 1 Unknown
28 enrolled
Sarcoma

Sarcoma

NCT05131386 2023-03-27

SYNERGIAS

Grupo Espanol de Investigacion en Sarcomas

Phase 2 Unknown
85 enrolled
Sarcoma

Bone Neoplasms, Chondrosarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT02359474 2023-02-28

HyperTET

Ludwig-Maximilians - University of Munich

Phase 2 Unknown
120 enrolled
Sarcoma

Sarcoma

NCT01772979 2013-01-21

MITO15

Catholic University of the Sacred Heart

Phase 2 Unknown
100 enrolled
Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡